Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

Thomas Urup; Linn Gillberg; Katja Kaastrup; Maya Jeje Schuang Lü; Signe Regner Michaelsen; Vibeke Andrée Larsen; Ib Jarle Christensen; Helle Broholm; Ulrik Lassen; Kirsten Grønbæk; Hans Skovgaard Poulsen

doi:10.1002/1878-0261.12660

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

Thomas Urup, Linn Gillberg, Katja Kaastrup, Maya Jeje Schuang Lü, Signe Regner Michaelsen, Vibeke Andrée Larsen, Ib Jarle Christensen, Helle Broholm, Ulrik Lassen, Kirsten Grønbæk, Hans Skovgaard Poulsen

Research output: Contribution to journal › Journal article › Research › peer-review

6 Citations (Scopus)

21 Downloads (Pure)

Original language	English
Journal	Molecular Oncology
Volume	14
Issue number	5
Pages (from-to)	964-973
ISSN	1574-7891
DOIs	https://doi.org/10.1002/1878-0261.12660
Publication status	Published - 2020

Access to Document

10.1002/1878-0261.12660Licence: CC BY

1878-0261.12660Final published version, 341 KBLicence: CC BY

Cite this

Urup, T., Gillberg, L., Kaastrup, K., Lü, M. J. S., Michaelsen, S. R., Andrée Larsen, V., Christensen, I. J., Broholm, H., Lassen, U., Grønbæk, K., & Poulsen, H. S. (2020). Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma. Molecular Oncology, 14(5), 964-973. https://doi.org/10.1002/1878-0261.12660

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma. / Urup, Thomas; Gillberg, Linn; Kaastrup, Katja; Lü, Maya Jeje Schuang; Michaelsen, Signe Regner; Andrée Larsen, Vibeke; Christensen, Ib Jarle; Broholm, Helle; Lassen, Ulrik ; Grønbæk, Kirsten; Poulsen, Hans Skovgaard.

In: Molecular Oncology, Vol. 14, No. 5, 2020, p. 964-973.

Research output: Contribution to journal › Journal article › Research › peer-review

Urup, Thomas ; Gillberg, Linn ; Kaastrup, Katja ; Lü, Maya Jeje Schuang ; Michaelsen, Signe Regner ; Andrée Larsen, Vibeke ; Christensen, Ib Jarle ; Broholm, Helle ; Lassen, Ulrik ; Grønbæk, Kirsten ; Poulsen, Hans Skovgaard. / Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma. In: Molecular Oncology. 2020 ; Vol. 14, No. 5. pp. 964-973.

@article{3098d5be935b4c84b39093f16eddb4fa,

title = "Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma",

author = "Thomas Urup and Linn Gillberg and Katja Kaastrup and L{\"u}, {Maya Jeje Schuang} and Michaelsen, {Signe Regner} and {Andr{\'e}e Larsen}, Vibeke and Christensen, {Ib Jarle} and Helle Broholm and Ulrik Lassen and Kirsten Gr{\o}nb{\ae}k and Poulsen, {Hans Skovgaard}",

year = "2020",

doi = "10.1002/1878-0261.12660",

language = "English",

volume = "14",

pages = "964--973",

journal = "Molecular Oncology",

issn = "1574-7891",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

AU - Urup, Thomas

AU - Gillberg, Linn

AU - Kaastrup, Katja

AU - Lü, Maya Jeje Schuang

AU - Michaelsen, Signe Regner

AU - Andrée Larsen, Vibeke

AU - Christensen, Ib Jarle

AU - Broholm, Helle

AU - Lassen, Ulrik

AU - Grønbæk, Kirsten

AU - Poulsen, Hans Skovgaard

PY - 2020

Y1 - 2020

U2 - 10.1002/1878-0261.12660

DO - 10.1002/1878-0261.12660

M3 - Journal article

C2 - 32133779

VL - 14

SP - 964

EP - 973

JO - Molecular Oncology

JF - Molecular Oncology

SN - 1574-7891

IS - 5

ER -